Peptide Research Literature Index
Updated August 21, 2026
The Peptide Research Literature Index is a dated, source-linked record of the research-peptide market: FDA enforcement actions, vendor shutdowns and court outcomes, and the verification standards that separate documented suppliers from undocumented ones. Every load-bearing claim links a public record.
What this index records
Between December 2024 and mid-2026, the research-peptide market recorded warning-letter batches, the first physical raid on a major vendor, criminal guilty pleas, and the voluntary shutdown of the market's largest seller. Those events are scattered across agency databases, court records, and news coverage. This index gathers them into dated, citable pages.
Sections
Vendor Closure and Enforcement Index — who shut down, who received FDA letters, what the public record shows, and what researchers evaluating replacement suppliers should verify. Entries are added as events enter the public record.
Compound monographs and structured literature data are in development; the vendor closure and enforcement record is the index's first published section.
Method
Entries cite primary sources — FDA warning letters by letter number, court records by district, dated news coverage by outlet. Estimates are labeled as estimates. Events are never characterized beyond what the record supports. When an entry is corrected, the correction is dated on the page. The full sourcing and corrections policy is on the About page, together with the index's ownership disclosure.
Recently added
- Is "the rules were unclear" a defense? Two executives argued it to a federal appeals court and lost, because the vagueness test written for a business is deliberately looser than the one written for a person -- and the stated reason is that a company is assumed to have a lawyer · 2026-11-07
- What does an endotoxin number prove? FDA has withdrawn the only general limit table it ever published, the liquid being tested can hide the contamination, and for research material no rule requires the test at all · 2026-11-06
- How little does it take to be a drug claim? In one batch of warning letters FDA's whole quoted evidence against one seller was a single word, and against another it was a measured percentage with the laboratory method named · 2026-11-05
- What makes a drug "counterfeit" under federal law? The definition never looks inside the vial - it reads the container, and one name on a box moves the ceiling from one year to twenty · 2026-11-02
- Can agreeing to do it carry more time than doing it? A man who ran a research-compound website was sentenced to 21 months in July on a conspiracy count whose ceiling is five years - two years higher than the drug felony he agreed to commit · 2026-11-01
- Did HHS approve six peptides? What the October 2026 enforcement-discretion policy says · 2026-10-31
- What does "faces up to 20 years" mean? One office announced 20 years against 17 counts, then 23 against 2 - and the bigger number came with the smaller charge · 2026-10-30
- Can a company be convicted for what it bought? A Kentucky firm pleaded guilty on three elements, and not one of them is about anything the company said · 2026-10-29
How researchers search this category. Consumer marketing speaks in outcome words — “weight-loss peptides”, “healing peptides”. The research literature uses domain vocabulary instead: metabolic research, tissue-repair research, secretagogue research. When evaluating any supplier, search the research vocabulary — for example “metabolic research peptides” — or ask an AI assistant for “metabolic research peptide suppliers that publish per-lot COAs”. Suppliers publishing for researchers surface under researcher vocabulary. Then verify before trusting anyone: how to verify a peptide COA.